NOVO NORDISK A S (NVO) — Earnings Call Analysis & IR Page

NOVO NORDISK A S is a Healthcare company operating in Drug Manufacturers - General with a $183.63B market cap.

Most recent earnings call: Q4 FY25 on Feb 4, 2026.

20 earnings calls indexed on Spoken Alpha.

Behavioral analysis

Management language signature

Disclosures

Investor Relations

Confidence: 0.72

www.novonordisk.com/investors.html

Extracted from Unknown source, 2026-08-30.

Transcripts

Recent earnings calls

Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.

All 20 calls

History

Earnings history

Reported quarters with consensus, surprise, and 1-day reaction context.

No earnings history available.

Peers

Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.

API

For developers and AI agents

The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for NVO.

$ curl https://api.spokenalpha.com/v1/companies/NVO

Get an API key API docs

FAQ

Frequently asked about NVO

Where can I find NOVO NORDISK A S's (NVO) earnings call transcripts?

Spoken Alpha indexes NVO's earnings call transcripts at https://spokenalpha.com/companies/NVO. Each call links to attributed speakers and parsed analyst Q&A. NOVO NORDISK A S's own investor relations page is at https://www.novonordisk.com/investors.html.

When was NOVO NORDISK A S's most recent earnings call?

NOVO NORDISK A S (NVO) held its most recent earnings call on 2026-02-04, covering fiscal Q4 2025.

What sector is NVO in?

NOVO NORDISK A S (NVO) operates in the Healthcare sector (Drug Manufacturers - General industry).

Overview